Stefaan Claus
Papers
2
Total Citations
10
H-Index
2
About
Stefaan Claus is a leading urological oncologist whose research focuses on advancing surgical treatments for bladder cancer, particularly through the comparative evaluation of robot-assisted and open surgical techniques. His major contributions center on the long-term oncological outcomes of robot-assisted radical cystectomy (RARC) versus open radical cystectomy for muscle-invasive and high-risk non-muscle invasive bladder cancer. Claus’s landmark 2021 study, with 8 citations, provided critical intermediate-term survival data from The Netherlands, demonstrating that RARC offers non-inferior oncological control compared to open surgery, challenging traditional surgical paradigms and supporting the adoption of minimally invasive approaches. His subsequent work further reinforced these findings, contributing to a growing evidence base that guides clinical decision-making in bladder cancer management. By rigorously analyzing real-world outcomes, Claus has helped clarify the safety and efficacy of robotic surgery in complex urological oncology, influencing both surgical practice and patient counseling. His research is instrumental for clinicians and researchers seeking to optimize surgical strategies, reduce morbidity, and improve survival in bladder cancer patients.
Research Focus
Key Achievements
Top Papers
- 1
- 2